The market for lab-developed tests, now worth $4.5 billion globally, is expected to see 7 percent compound annual growth through 2028, according to a new Research and Markets report.
Lab
Spanish startup Mecwins is developing in vitro diagnostic testing lab technology that detects concentrations in femtograms per milliliter — 1,000 times more sensitive than widely available enzyme-linked immunosorbent assays, the company said Sept. 24.
Staff shortages are forcing the University of Rochester (N.Y.) Medical Center to temporarily close 11 labs, the university said Sept. 23.
Two COVID-19 lab test kits made by Abbott Molecular could show false positive results, the FDA said Sept. 20.
The past two years have caused staffing issues in many areas of healthcare, but medical labs had already been struggling to hire enough people before the COVID-19 pandemic's onset.
Advertisement
The CDC is making a push to bolster medical labs around the country, the agency said Sept. 17.
Congress is considering two bills that would regulate lab tests designed in-house, and the senior author of a new study focused on the tests, published in the Journal of Molecular Diagnostics, said he thinks it's warranted.
Demand in the lab real estate market is driven partially by pharmaceutical sales, which are predicted to grow at a compound annual rate of 7.4 percent through 2026, according to a Sept. 15 report by Chicago-based commercial real estate firm…
Shanghai-based biopharmaceutical company Zai Lab is ramping up its U.S. operations with a Cambridge, Mass., office, the company said Sept. 16.
New York City-based Weill Cornell Medicine will build new research labs and upgrade its clinical and virology labs with funds from a $1.5 billion fundraising campaign, the school said Sept. 14. Weill Cornell has raised more than half that so…